Syndax Pharmaceuticals announces positive Phase 2 trial results for revumenib in relapsed/refractory mNPM1 AML, with key ...

Unipcs' prediction of a massive rally for Bonk gains traction following its 12% spike in a single day. Another trader ...

Analysts expect Bitcoin Depot to report an earnings per share (EPS) of $0.00. Bitcoin Depot bulls will hope to hear the ...

Analysts estimate that Stronghold Digital Mining will report an earnings per share (EPS) of $-0.51. The announcement from ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of ...

Cronos' Q3 net revenue totaled $34.3 million, up by $9.5 million year-over-year. Q3 net income totaled $7.3 million compared ...

Raoul Pal, CEO of Real Vision, has suggested that Ethereum (CRYPTO: ETH) could benefit more than Bitcoin (CRYPTO: BTC) ...

Enveric Biosciences licenses its EB-002 drug candidate to MycoMedica Life Sciences, focusing on mental health treatment ...

A new SEC filing reveals that Jonathan Steinberg, Chief Executive Officer at WisdomTree WT, made a notable insider purchase ...

The Organization of Petroleum Exporting Countries (OPEC) has once again revised its oil demand growth forecasts for 2024, ...

Chinese markets drop as Trump considers China hawks for top roles, sparking fears of tougher stance. Yuan tumbles, stocks in ...